Lucid Diagnostics Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 208.7% | 140.1% | 165.4% | 165.4% | 143.7% | 179.2% | 187.3% | 153.5% | 140.1% | 123.7% | 147.1% | 98.0% | 125.8% | |
| -108.7% | -40.1% | -65.4% | -65.4% | -43.7% | -79.2% | -87.3% | -53.5% | -40.1% | -23.7% | -47.1% | 2.0% | -25.8% | |
| 206.3% | 184.4% | 150.0% | 140.6% | 142.2% | 121.4% | 172.5% | 107.9% | 105.0% | 114.6% | 96.0% | 80.9% | 99.0% | |
| 551.7% | 404.3% | 406.6% | 498.7% | 456.9% | 489.9% | 744.2% | 482,975.1% | 462.8% | 431.1% | 432,484.1% | 390.6% | 100,089.0% | |
| 1,312.5% | 1,061.2% | 1,012.7% | 1,081.4% | 954.1% | 954.6% | 1,420.8% | 925.4% | 930.9% | 907.9% | 917.4% | 870.4% | 905.1% | |
| -1,421.2% | -1,101.3% | -1,078.1% | -1,146.7% | -997.8% | -1,033.8% | -1,508.1% | -978.8% | -971.0% | -931.6% | -964.5% | -868.5% | -930.9% | |
| 19.0% | 1.1% | 1.2% | 0.6% | 0.1% | 0.6% | 1.1% | 0.5% | 0.2% | 0.4% | 0.5% | 0.3% | 0.3% | |
| -1,814.6% | -1,041.3% | -1,060.1% | -1,127.6% | -1,055.5% | -964.2% | -3,249.8% | -381.7% | -858.5% | -1,081.5% | -1,107.4% | -792.9% | -959.8% | |
| -366.8% | -188,495.3% | 748,851.1% | – | -1,054,490.5% | 626,232.2% | 1,100,241.5% | 296,560.6% | – | – | 773,805.7% | 205,427.4% | – | |
| -1,814.6% | -1,041.3% | -1,060.1% | -1,127.6% | -1,055.5% | -964.2% | -3,249.8% | -381.7% | -858.5% | -1,081.5% | -1,107.4% | -792.9% | -959.8% | |
| -1,715.7% | -979.8% | -1,008.9% | -1,103.5% | -1,037.1% | -945.0% | -3,222.0% | -362.1% | -840.2% | -1,067.2% | -1,089.3% | -777.4% | -943.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.